Published in Pediatrics on January 01, 2010
A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD | NCT02758496
An Open Label Study of CM-AT for the Treatment of Children With Autism | NCT02649959
A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study) | NCT02410902
Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell (2013) 8.11
The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci (2011) 2.61
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry (2011) 2.28
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry (2011) 1.85
Maternal infection and immune involvement in autism. Trends Mol Med (2011) 1.78
Autism spectrum disorder: advances in evidence-based practice. CMAJ (2014) 1.76
Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One (2011) 1.74
Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors. Autism Res (2012) 1.55
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2012) 1.33
Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord (2014) 1.26
Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res (2011) 1.24
Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr (2012) 1.20
Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology (2011) 1.15
Anxiety, sensory over-responsivity, and gastrointestinal problems in children with autism spectrum disorders. J Abnorm Child Psychol (2013) 1.14
Medical comorbidities in autism: challenges to diagnosis and treatment. Neurotherapeutics (2010) 1.13
Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. BMC Neurol (2011) 1.12
Effect of a vitamin/mineral supplement on children and adults with autism. BMC Pediatr (2011) 1.05
The gut microbiome: a new frontier in autism research. Curr Psychiatry Rep (2013) 1.03
Primary care for adults on the autism spectrum. Med Clin North Am (2014) 1.02
Redox metabolism abnormalities in autistic children associated with mitochondrial disease. Transl Psychiatry (2013) 1.00
The promise and the pitfalls of autism research: an introductory note for new autism researchers. Brain Res (2010) 0.99
Drug discovery for autism spectrum disorder: challenges and opportunities. Nat Rev Drug Discov (2013) 0.99
The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract (2011) 0.96
A microbial association with autism. MBio (2012) 0.96
Brief report: Association between behavioral features and gastrointestinal problems among children with autism spectrum disorder. J Autism Dev Disord (2012) 0.95
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clin Ther (2015) 0.95
Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism. Autism Res Treat (2012) 0.94
Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study. Transl Psychiatry (2013) 0.93
Anatomical localization of commensal bacteria in immune cell homeostasis and disease. Immunol Rev (2014) 0.92
The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders. Psychopharmacology (Berl) (2013) 0.91
Brief report: Emergency department utilization by individuals with autism. J Autism Dev Disord (2015) 0.90
Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder. Biol Psychiatry (2016) 0.89
Gluten- and casein-free dietary intervention for autism spectrum conditions. Front Hum Neurosci (2013) 0.89
Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters. BMC Psychiatry (2016) 0.88
Identification of unique gene expression profile in children with regressive autism spectrum disorder (ASD) and ileocolitis. PLoS One (2013) 0.88
Antibodies against food antigens in patients with autistic spectrum disorders. Biomed Res Int (2013) 0.88
Immune dysregulation in autism spectrum disorder. Eur J Pediatr (2013) 0.88
Association of maternal report of infant and toddler gastrointestinal symptoms with autism: evidence from a prospective birth cohort. JAMA Psychiatry (2015) 0.88
Autism Spectrum Disorder: Defining Dimensions and Subgroups. Curr Dev Disord Rep (2014) 0.86
A nationwide study of the association between celiac disease and the risk of autistic spectrum disorders. JAMA Psychiatry (2013) 0.86
US perspective on gluten-related diseases. Clin Exp Gastroenterol (2014) 0.85
Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice. Front Mol Neurosci (2014) 0.85
The clinical-basic interface in defining pathogenesis in disorders of neurodevelopmental origin. Neuron (2010) 0.85
The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood. Clin Med Insights Pediatr (2016) 0.84
Current perspectives on physical activity and exercise recommendations for children and adolescents with autism spectrum disorders. Phys Ther (2014) 0.84
A "bottom-up" approach to aetiological research in autism spectrum disorders. Front Hum Neurosci (2013) 0.84
Parent-reported gastro-intestinal symptoms in children with autism spectrum disorders. J Autism Dev Disord (2013) 0.83
Patterns of Risk for Multiple Co-Occurring Medical Conditions Replicate Across Distinct Cohorts of Children with Autism Spectrum Disorder. Autism Res (2015) 0.83
Zinc in gut-brain interaction in autism and neurological disorders. Neural Plast (2015) 0.83
Interactions of innate and adaptive immunity in brain development and function. Brain Res (2014) 0.83
Brief report: "allergic symptoms" in children with Autism Spectrum Disorders. More than meets the eye? J Autism Dev Disord (2011) 0.83
Autism and pediatric practice: toward a medical home. J Autism Dev Disord (2012) 0.83
Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes. Clin Med Insights Pediatr (2016) 0.82
A pilot open-label trial of minocycline in patients with autism and regressive features. J Neurodev Disord (2013) 0.82
Enrichment of elevated plasma F2t-isoprostane levels in individuals with autism who are stratified by presence of gastrointestinal dysfunction. PLoS One (2013) 0.82
Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl Psychiatry (2015) 0.81
The medical care of children with autism. Eur J Pediatr (2012) 0.81
Hyperbaric oxygen treatment in autism spectrum disorders. Med Gas Res (2012) 0.81
The association between emotional and behavioral problems and gastrointestinal symptoms among children with high-functioning autism. Autism (2013) 0.80
Autism spectrum disorder in children born preterm-role of exposure to perinatal inflammation. Front Neurosci (2013) 0.80
Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. J Child Adolesc Psychopharmacol (2011) 0.80
Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder. J Neuroinflammation (2013) 0.80
Using genetic findings in autism for the development of new pharmaceutical compounds. Psychopharmacology (Berl) (2013) 0.80
Modeling autism: a systems biology approach. J Clin Bioinforma (2012) 0.79
Dietary intake and plasma levels of choline and betaine in children with autism spectrum disorders. Autism Res Treat (2013) 0.79
Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance. World J Gastroenterol (2014) 0.79
Nutritional status survey of children with autism and typically developing children aged 4-6 years in Heilongjiang Province, China. J Nutr Sci (2013) 0.78
Utilization patterns of conventional and complementary/alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study. J Dev Behav Pediatr (2014) 0.78
Sleep Disorder, Gastrointestinal Problems and Behaviour Problems Seen in Autism Spectrum Disorder Children and Yoga as Therapy: A Descriptive Review. J Clin Diagn Res (2016) 0.78
Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism. Transl Psychiatry (2014) 0.78
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach. Semin Immunopathol (2014) 0.78
Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional Analysis. Drugs Real World Outcomes (2016) 0.78
The Gluten-Free/Casein-Free Diet: A Double-Blind Challenge Trial in Children with Autism. J Autism Dev Disord (2016) 0.77
Parent and pediatrician perspectives regarding the primary care of children with autism spectrum disorders. J Autism Dev Disord (2013) 0.77
Potential Role of Selenoenzymes and Antioxidant Metabolism in relation to Autism Etiology and Pathology. Autism Res Treat (2014) 0.77
Impact of prenatal environmental stress on cortical development. Front Cell Neurosci (2015) 0.77
What Every Behavior Analyst Should Know About the "MMR Causes Autism" Hypothesis. Behav Anal Pract (2010) 0.77
Exploring perceptions and use of the electronic health record by parents of children with autism spectrum disorder: A qualitative study. Health Informatics J (2015) 0.77
A Profile on Emergency Department Utilization in Adolescents and Young Adults with Autism Spectrum Disorders. J Autism Dev Disord (2016) 0.77
The role of nutraceuticals in the management of autism. Saudi Pharm J (2012) 0.76
Distant Site Effects of Ingested Prebiotics. Nutrients (2016) 0.76
The Brain-Gut-Microbiome Axis: What Role Does It Play in Autism Spectrum Disorder? Curr Dev Disord Rep (2016) 0.76
Gut Microbiota and Autism: Key Concepts and Findings. J Autism Dev Disord (2016) 0.76
A Randomized, Placebo-controlled Trial of Digestive Enzymes in Children with Autism Spectrum Disorders. Clin Psychopharmacol Neurosci (2015) 0.75
Can probiotics benefit children with autism spectrum disorders? World J Gastroenterol (2016) 0.75
Medical and Behavioral Correlates of Depression History in Children and Adolescents With Autism Spectrum Disorder. Pediatrics (2016) 0.75
Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism (2016) 0.75
Autism spectrum disorder in adults: diagnosis, management, and health services development. Neuropsychiatr Dis Treat (2016) 0.75
Dietary Patterns of Children with Autism Spectrum Disorder: A Study Based in Egypt. Open Access Maced J Med Sci (2015) 0.75
Use and Perceived Effectiveness of Complementary and Alternative Medicine to Treat and Manage the Symptoms of Autism in Children: A Survey of Parents in a Community Population. J Altern Complement Med (2015) 0.75
Maladaptive Behavior and Gastrointestinal Disorders in Children with Autism Spectrum Disorder. Pediatr Gastroenterol Hepatol Nutr (2015) 0.75
Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder. Cell Mol Gastroenterol Hepatol (2016) 0.75
A Putative Blood-Based Biomarker for Autism Spectrum Disorder-Associated Ileocolitis. Sci Rep (2016) 0.75
The second brain in autism spectrum disorder: could connexin 43 expressed in enteric glial cells play a role? Front Cell Neurosci (2015) 0.75
Breast Milk Protects Against Gastrointestinal Symptoms in Infants at High Risk for Autism During Early Development. J Pediatr Gastroenterol Nutr (2016) 0.75
Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders? PLoS One (2015) 0.75
Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression. Transl Psychiatry (2015) 0.75
Serological screening for Celiac Disease in 382 pre-schoolers with Autism Spectrum Disorder. Ital J Pediatr (2016) 0.75
A Framework for Developing a Curriculum Regarding Autism Spectrum Disorders for Primary Care Providers. J Clin Diagn Res (2015) 0.75
Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med (2013) 15.85
The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol (2010) 13.99
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron (2011) 10.61
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39
Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol (2007) 6.96
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol (2013) 5.09
Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med (2012) 4.97
Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain (2008) 4.59
The epidemiology of autism spectrum disorders. Annu Rev Public Health (2007) 4.52
Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 4.36
Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet (2008) 4.10
Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest (2002) 4.05
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology (2004) 4.04
Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest (2004) 3.90
Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc (2005) 3.82
Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med (2003) 3.71
A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A (2006) 3.55
Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS One (2007) 3.53
Development and validation of a CGH microarray for clinical cytogenetic diagnosis. Genet Med (2005) 3.39
Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet (2009) 3.33
Race differences in the age at diagnosis among medicaid-eligible children with autism. J Am Acad Child Adolesc Psychiatry (2002) 3.33
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology (2006) 3.32
Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr (2005) 3.08
Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev (2007) 3.08
Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology (2008) 2.99
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98
Detection of clinically relevant exonic copy-number changes by array CGH. Hum Mutat (2010) 2.93
Eosinophils in the esophagus--peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol (2006) 2.92
Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A (2006) 2.86
A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms. J Am Acad Child Adolesc Psychiatry (2008) 2.82
Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med (2006) 2.78
Epigenetics and human disease. Annu Rev Genomics Hum Genet (2004) 2.78
A transient placental source of serotonin for the fetal forebrain. Nature (2011) 2.71
Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci (2007) 2.70
The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci (2011) 2.61
The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet (2007) 2.60
Daily consumption of Indian spinach (Basella alba) or sweet potatoes has a positive effect on total-body vitamin A stores in Bangladeshi men. Am J Clin Nutr (2004) 2.59
Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology (2002) 2.52
Increased LIS1 expression affects human and mouse brain development. Nat Genet (2009) 2.45
Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol (2005) 2.39
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet (2011) 2.38
Bacterial artificial chromosome-emulation oligonucleotide arrays for targeted clinical array-comparative genomic hybridization analyses. Genet Med (2008) 2.36
Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci (2009) 2.33
Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings. Ann Neurol (2012) 2.33
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med (2010) 2.32
Consensus paper: pathological role of the cerebellum in autism. Cerebellum (2012) 2.32
Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther (2004) 2.32
Individual, family, and societal dimensions of genetic discrimination: a case study analysis. Sci Eng Ethics (1996) 2.25
A yoga intervention for young adults with elevated symptoms of depression. Altern Ther Health Med (2004) 2.22
Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J Neurosci (2011) 2.21
5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci (2009) 2.21
Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci (2003) 2.18
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Factor structure of the brief symptom inventory--18 in adult survivors of childhood cancer: results from the childhood cancer survivor study. Psychol Assess (2006) 2.08
Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol (2007) 2.04
MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism. Autism Res (2010) 2.03
Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol (2007) 2.02
Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci U S A (2002) 2.01
Genomic imbalances in neonates with birth defects: high detection rates by using chromosomal microarray analysis. Pediatrics (2008) 2.00
Auditory magnetic mismatch field latency: a biomarker for language impairment in autism. Biol Psychiatry (2011) 1.99
The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut (2012) 1.98
Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region. Genet Med (2007) 1.98
A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet (2009) 1.98
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol (2010) 1.96
Single parents of children with chronic illness: an understudied phenomenon. J Pediatr Psychol (2007) 1.95
Screening strategies for autism spectrum disorders in pediatric primary care. J Dev Behav Pediatr (2008) 1.94
Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J Neurosci (2003) 1.93
Socioeconomic inequality in the prevalence of autism spectrum disorder: evidence from a U.S. cross-sectional study. PLoS One (2010) 1.93
Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1. Blood (2002) 1.92
The use of medical records in research: what do patients want? J Law Med Ethics (2003) 1.91
Disparities in diagnoses received prior to a diagnosis of autism spectrum disorder. J Autism Dev Disord (2006) 1.91
Long-lived intestinal tuft cells serve as colon cancer-initiating cells. J Clin Invest (2014) 1.90
The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology (2011) 1.88
How the timing and quality of early experiences influence the development of brain architecture. Child Dev (2010) 1.87
Microarray-based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics. Am J Med Genet A (2007) 1.85
A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2009) 1.85
A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc Natl Acad Sci U S A (2012) 1.85
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol (2011) 1.82
A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A (2004) 1.79
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79
Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2003) 1.78
Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn (2009) 1.78
High-resolution EUS in children with eosinophilic "allergic" esophagitis. Gastrointest Endosc (2003) 1.77
Early experience modifies the postnatal assembly of autonomic emotional motor circuits in rats. J Neurosci (2005) 1.76
Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism. Nat Genet (2013) 1.76
Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci U S A (2006) 1.75
The organization of the transcriptional network in specific neuronal classes. Mol Syst Biol (2009) 1.74
Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One (2011) 1.74
Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr (2006) 1.74
Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum Gene Ther (2002) 1.69
Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut (2013) 1.69
Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One (2008) 1.68